现实生活研究中生物可吸收血管支架失败的发生与处理
Occurrence and management of bioresorbable vascular scaffold failure in real-life studies.
作者信息
Cortese Bernardo, Elwany Mostafa
机构信息
Interventional Cardiology, ASST Fatebenefratelli Sacco, Milano, Italy.
Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Massa, Italy.
出版信息
J Thorac Dis. 2017 Aug;9(Suppl 9):S935-S939. doi: 10.21037/jtd.2017.06.82.
Abstract
Bioresorbable vascular scaffold (BVS) has emerged as a new technology aiming at overcoming some drawbacks of the conventional metallic stent. In spite of the initial promising results, this technology stumbled upon numerous challenges, which were revealed in the real world studies. Thanks to real world trials and registries findings, our knowledge about the BVS has grown over time, thus we have understood on BVS behavior in various settings and formulated better implantation techniques. In this article, we will review the incidence of BVS failure in real world studies, its different etiologies and management strategies.
摘要
生物可吸收血管支架（BVS）已成为一项旨在克服传统金属支架某些缺点的新技术。尽管最初取得了令人鼓舞的结果，但这项技术在现实世界研究中遇到了众多挑战。得益于现实世界试验和注册研究的结果，我们对BVS的了解随着时间的推移不断增加，因此我们已经了解了BVS在各种情况下的表现，并制定了更好的植入技术。在本文中，我们将回顾现实世界研究中BVS失败的发生率、其不同病因及管理策略。
相似文献
1
Occurrence and management of bioresorbable vascular scaffold failure in real-life studies.现实生活研究中生物可吸收血管支架失败的发生与处理
J Thorac Dis. 2017 Aug;9(Suppl 9):S935-S939. doi: 10.21037/jtd.2017.06.82.
2
Real-World Bioresorbable Vascular Scaffold Experience Compared With Second-Generation Metallic Drug-Eluting Stents in Complex Coronary Lesions.复杂冠状动脉病变中生物可吸收血管支架与第二代金属药物洗脱支架的真实世界经验比较
J Invasive Cardiol. 2018 Jul;30(7):251-255. Epub 2018 Apr 15.
3
Patient profile and periprocedural outcomes of bioresorbable vascular scaffold implantation in comparison with drug-eluting and bare-metal stent implantation. Experience from ORPKI Polish National Registry 2014-2015.生物可吸收血管支架植入与药物洗脱支架及裸金属支架植入相比的患者资料及围手术期结果。来自2014 - 2015年波兰国家心血管介入注册中心（ORPKI）的经验。
Postepy Kardiol Interwencyjnej. 2016;12(4):321-328. doi: 10.5114/aic.2016.63632. Epub 2016 Nov 17.
4
Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: an interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials.在 ABSORB-EXTEND 单臂试验中，435 例患者接受依维莫司洗脱生物可吸收血管支架治疗后小分支闭塞的发生率及短期临床结局：与 SPIRIT 试验 I 和 II 中依维莫司洗脱金属支架的比较。
JACC Cardiovasc Interv. 2013 Mar;6(3):247-57. doi: 10.1016/j.jcin.2012.10.013.
5
Very Late Scaffold Thrombosis of Bioresorbable Vascular Scaffold: Systematic Review and a Meta-Analysis.生物可吸收血管支架的极晚期支架血栓：系统评价和荟萃分析。
JACC Cardiovasc Interv. 2017 Jan 9;10(1):27-37. doi: 10.1016/j.jcin.2016.10.027.
6
The Current Literature on Bioabsorbable Stents: a Review.生物可吸收支架的最新文献综述。
Curr Atheroscler Rep. 2019 Nov 25;21(12):54. doi: 10.1007/s11883-019-0816-4.
7
Bioresorbable vascular scaffold versus metallic stent in percutaneous coronary intervention: results of the AIDA trial.生物可吸收血管支架与金属支架在经皮冠状动脉介入治疗中的比较：AIDA试验结果
J Community Hosp Intern Med Perspect. 2017 Oct 18;7(5):307-308. doi: 10.1080/20009666.2017.1374111. eCollection 2017.
8
Vascular restoration therapy and bioresorbable vascular scaffold.血管修复治疗和生物可吸收血管支架。
Regen Biomater. 2014 Nov;1(1):49-55. doi: 10.1093/rb/rbu005. Epub 2014 Oct 20.
9
Comparison of early clinical outcomes between ABSORB bioresorbable vascular scaffold and everolimus-eluting stent implantation in a real-world population.真实世界人群中ABSORB生物可吸收血管支架与依维莫司洗脱支架植入早期临床结局的比较
Catheter Cardiovasc Interv. 2015 Jan 1;85(1):E10-5. doi: 10.1002/ccd.25569. Epub 2014 Jul 16.
10
Twelve-Month Outcomes With a Bioresorbable Everolimus-Eluting Scaffold: Results of the ESHC-BVS Registry at Two Australian Centers.生物可吸收依维莫司洗脱支架的12个月结果：澳大利亚两个中心的ESHC-BVS注册研究结果
J Invasive Cardiol. 2016 Aug;28(8):316-22. Epub 2015 Nov 15.
本文引用的文献
1
First experience of drug-coated balloons for treatment of bioresorbable vascular scaffold restenosis.药物涂层球囊治疗生物可吸收血管支架再狭窄的首次经验。
Cardiovasc Revasc Med. 2017 Oct-Nov;18(7):482-486. doi: 10.1016/j.carrev.2017.03.020. Epub 2017 Mar 25.
2
Restenosis of Coronary Bioresorbable Vascular Scaffolds.冠状动脉生物可吸收血管支架再狭窄
Rev Esp Cardiol (Engl Ed). 2017 Jul;70(7):527-531. doi: 10.1016/j.rec.2017.02.024. Epub 2017 Mar 9.
3
Very Late Scaffold Thrombosis of Bioresorbable Vascular Scaffold: Systematic Review and a Meta-Analysis.生物可吸收血管支架的极晚期支架血栓：系统评价和荟萃分析。
JACC Cardiovasc Interv. 2017 Jan 9;10(1):27-37. doi: 10.1016/j.jcin.2016.10.027.
4
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.对比依维莫司洗脱生物可吸收支架与依维莫司洗脱金属支架治疗冠状动脉狭窄的疗效（ABSORB II）：3 年随机、对照、单盲、多中心临床试验。
Lancet. 2016 Nov 19;388(10059):2479-2491. doi: 10.1016/S0140-6736(16)32050-5. Epub 2016 Oct 30.
5
Comparative Characterization of Biomechanical Behavior and Healing Profile of a Novel Ultra-High-Molecular-Weight Amorphous Poly-l-Lactic Acid Sirolimus-Eluting Bioresorbable Coronary Scaffold.新型超高分子量无定形聚左旋乳酸西罗莫司洗脱生物可吸收冠状动脉支架的生物力学行为和愈合情况的比较特征
Circ Cardiovasc Interv. 2016 Oct;9(10). doi: 10.1161/CIRCINTERVENTIONS.116.004253.
6
First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis.首次报道使用药物涂层球囊治疗生物可吸收支架内再狭窄。
Catheter Cardiovasc Interv. 2017 Mar 1;89(4):676-678. doi: 10.1002/ccd.26803. Epub 2016 Sep 21.
7
Overview of the 2016 U.S. Food and Drug Administration Circulatory System Devices Advisory Panel Meeting on the Absorb Bioresorbable Vascular Scaffold System.2016 年美国食品和药物管理局循环系统设备顾问小组会议概述：Absorb 生物可吸收血管支架系统。
JACC Cardiovasc Interv. 2016 Sep 12;9(17):1757-64. doi: 10.1016/j.jcin.2016.06.027.
8
The Contemporary Pulse of Bioresorbable-Scaffold Thrombosis Among Expert Operators.
J Am Coll Cardiol. 2016 Jun 21;67(24):2905-6. doi: 10.1016/j.jacc.2016.03.576.
9
Platelet reactivity over time in coronary artery disease patients treated with a bioabsorbable everolimus-eluting scaffold.
Platelets. 2016 Dec;27(8):777-783. doi: 10.1080/09537104.2016.1184750. Epub 2016 Jun 2.
10
Impact of the bioresorbable vascular scaffold surface area on on-treatment platelet reactivity.
Platelets. 2016 Jul;27(5):446-51. doi: 10.3109/09537104.2016.1143918. Epub 2016 Mar 4.
Zotero 插件